Twist Bioscience (TWST) Equity Ratio (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Equity Ratio data on file, last reported at 0.67 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.67, down 8.92% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.67 (down 8.92% YoY), and the FY2025 annual result was 0.74, down 4.24% from the prior year.
• Equity Ratio fell to 0.67 in Q1 2026 per TWST's latest filing, from 0.71 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.85 in Q1 2022 and troughed at 0.67 in Q1 2026.
• A 5-year average of 0.78 and a median of 0.8 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2026: Equity Ratio rose 2.97% in 2022, then slipped 8.92% in 2026.
• A 5-year view of Equity Ratio shows it stood at 0.82 in 2022, then retreated by 1.83% to 0.81 in 2023, then retreated by 6.95% to 0.75 in 2024, then slipped by 4.59% to 0.71 in 2025, then decreased by 5.85% to 0.67 in 2026.
• Business Quant data shows TWST's Equity Ratio at 0.67 in Q1 2026, 0.71 in Q4 2025, and 0.74 in Q3 2025.